GB9226370D0 - Nitrogen heterocycle paf receptor antagonists - Google Patents
Nitrogen heterocycle paf receptor antagonistsInfo
- Publication number
- GB9226370D0 GB9226370D0 GB929226370A GB9226370A GB9226370D0 GB 9226370 D0 GB9226370 D0 GB 9226370D0 GB 929226370 A GB929226370 A GB 929226370A GB 9226370 A GB9226370 A GB 9226370A GB 9226370 D0 GB9226370 D0 GB 9226370D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- receptor antagonists
- nitrogen heterocycle
- paf receptor
- paf
- heterocycle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929200210A GB9200210D0 (en) | 1992-01-07 | 1992-01-07 | Compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB9226370D0 true GB9226370D0 (en) | 1993-02-10 |
| GB2263109A GB2263109A (en) | 1993-07-14 |
| GB2263109B GB2263109B (en) | 1996-05-01 |
Family
ID=10708190
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB929200210A Pending GB9200210D0 (en) | 1992-01-07 | 1992-01-07 | Compounds |
| GB9226370A Expired - Fee Related GB2263109B (en) | 1992-01-07 | 1992-12-16 | Nitrogen heterocycle PAF receptor antagonists |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB929200210A Pending GB9200210D0 (en) | 1992-01-07 | 1992-01-07 | Compounds |
Country Status (1)
| Country | Link |
|---|---|
| GB (2) | GB9200210D0 (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2140034A1 (en) | 1992-07-13 | 1994-01-20 | Xiong Cai | 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
| US5463083A (en) * | 1992-07-13 | 1995-10-31 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| US5434151A (en) * | 1992-08-24 | 1995-07-18 | Cytomed, Inc. | Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
| US5703093A (en) * | 1995-05-31 | 1997-12-30 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| US6201016B1 (en) | 1994-06-27 | 2001-03-13 | Cytomed Incorporated | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| US5750565A (en) * | 1995-05-25 | 1998-05-12 | Cytomed, Inc. | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| US5792776A (en) * | 1994-06-27 | 1998-08-11 | Cytomed, Inc., | Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| DE19605766A1 (en) * | 1996-02-16 | 1997-08-21 | Basf Ag | Substituted 2-phenylpyridines |
| US6747027B1 (en) | 1996-07-22 | 2004-06-08 | Pharmacia Corporation | Thiol sulfonamide metalloprotease inhibitors |
| WO1998003164A1 (en) * | 1996-07-22 | 1998-01-29 | Monsanto Company | Thiol sulfone metalloprotease inhibitors |
| DE19719621A1 (en) * | 1997-05-09 | 1998-11-12 | Hoechst Ag | Sulfonylaminocarboxylic acids |
| US6800646B1 (en) | 1999-02-08 | 2004-10-05 | Pharmacia Corporation | Sulfamato hydroxamic acid metalloprotease inhibitor |
| CA2774959C (en) | 2000-08-04 | 2016-05-31 | Dmi Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
| US6645990B2 (en) | 2000-08-15 | 2003-11-11 | Amgen Inc. | Thiazolyl urea compounds and methods of uses |
| US7119203B2 (en) | 2002-04-25 | 2006-10-10 | Pharmacia Corporation | Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| CA2500652A1 (en) | 2002-10-02 | 2004-04-15 | Dmi Biosciences, Inc. | Diagnosis and monitoring of diseases |
| JP2007500747A (en) | 2003-05-15 | 2007-01-18 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | Treatment of T cell mediated diseases |
| AP2007004161A0 (en) | 2005-04-28 | 2007-10-31 | Pfizer Ltd | Amino acid derivatives |
| JP5544458B2 (en) | 2005-07-12 | 2014-07-09 | アンピオ ファーマシューティカルズ，インコーポレイテッド | Method of using trilostane III in the manufacture of a pharmaceutical product for treating disease and pharmaceutical product comprising trirostan III |
| JP5856843B2 (en) | 2008-05-27 | 2016-02-10 | アンピオ ファーマシューティカルズ，インコーポレイテッド | Pharmaceutical composition using diketopiperazine |
| SG2014008171A (en) | 2009-06-22 | 2014-04-28 | Ampio Pharmaceuticals Inc | Method for treatment of diseases |
| CA2810844C (en) | 2010-09-07 | 2017-03-21 | Dmi Acquisition Corp. | Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions |
| SG10201608087WA (en) | 2011-10-10 | 2016-11-29 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
| EP2766029B1 (en) | 2011-10-10 | 2020-03-25 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
| MX355446B (en) | 2011-10-28 | 2018-04-18 | Ampio Pharmaceuticals Inc | Treatment of rhinitis. |
| US9351979B2 (en) | 2012-12-19 | 2016-05-31 | Ampio Pharmaceuticals, Inc. | Methods of treatment of diseases |
| CA2906864A1 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| KR20170045274A (en) | 2014-08-18 | 2017-04-26 | 앰피오 파마슈티컬스 인코퍼레이티드 | Treatment of joint conditions |
| US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3610848A1 (en) * | 1986-04-01 | 1987-10-15 | Boehringer Ingelheim Kg | NEW 1,4-DIAZEPINE |
| CN1030415A (en) * | 1987-02-20 | 1989-01-18 | 山之内制药株式会社 | Saturated heterocycle carboxamide derivatives and its preparation method |
| US4992455A (en) * | 1987-05-22 | 1991-02-12 | Sumitomo Pharmaceuticals Company, Limited | Thiazolidin-4-one derivatives useful for treating diseases caused by platelet activating factor |
-
1992
- 1992-01-07 GB GB929200210A patent/GB9200210D0/en active Pending
- 1992-12-16 GB GB9226370A patent/GB2263109B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| GB9200210D0 (en) | 1992-02-26 |
| GB2263109A (en) | 1993-07-14 |
| GB2263109B (en) | 1996-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2263109B (en) | Nitrogen heterocycle PAF receptor antagonists | |
| EP0673247A4 (en) | Fibrinogen receptor antagonists. | |
| EP0667773A4 (en) | Fibrinogen receptor antagonists. | |
| HU9302246D0 (en) | Substituted heterocyclic compounds containing nitrogen | |
| SG65570A1 (en) | Heterobicyclic compounds | |
| HU9301603D0 (en) | Angiotensine 11 antagonists | |
| ZA92600B (en) | Lhrh antagonists | |
| HU913074D0 (en) | Fibrinogenic receptor antagonists | |
| GB9202585D0 (en) | Nitrogen heterocycles | |
| EP0522782A3 (en) | Cordless telephone system for moving conveyances | |
| HU9501073D0 (en) | Benzofuran derivatives as 5-hti-like receptor antagonists | |
| GB9320799D0 (en) | Fibrinogen receptor antagonists | |
| HU9501693D0 (en) | Benzazepinone derivatives | |
| EP0565484A3 (en) | Hiv-protease inhibiting morpholin- and thiomorpholin-4-ylamides | |
| HK110397A (en) | Arrangement for connecting rails | |
| GB2264115B (en) | 1H-2-Methylimidazo(4,5-c)pyridinyl Derivatives as PAF Antagonists | |
| NZ241872A (en) | Substituted oxaspirononane paf antagonists | |
| GB9005843D0 (en) | Nitrogen heterocycles | |
| ZA931064B (en) | Derivatives of saturated nitrogen heterocycles. | |
| IL106287A0 (en) | Receptor derivatives | |
| ZA934873B (en) | Receptor derivatives | |
| GB9212427D0 (en) | Receptor cloning | |
| GB9223769D0 (en) | Receptor cloning | |
| GB9326065D0 (en) | Compensation device | |
| GB2273963B (en) | Improved compensator device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19971216 |